Status: Not yet recruiting
A Study of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Adults
The goal of this intervention study is to assess the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in Healthy Participants. The main parameters it aims to answer are: Does a single dose of HCXT-2001 Tablets and HCXT-2001 Tablets(A) in healthy participants impact the Safety, Tolerability, Pharmacokinetics, and Immunogenicity profiles? This study will be a randomized, double blind, placebo-controlled study.
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-45Biological sex: AllType: InterventionalSponsor: Shanghai Peptidstar Therapeutics LimitedUpdated: Oct 13, 2026Locations: 3
Eligibility criteria
Body weight ≥ 50 kg for males and ≥ 45 kg for females, and body mass index (BMI)... [+3]
History or presence of immunological diseases. [+15]